Whole Cell Therapeutic Vaccine Modified With Hyper-IL6 for Combinational Treatment of Nonresected Advanced Melanoma

Active specific immunotherapy of cancer requires an efficient induction and effector phase. The induction covers potent activation of anti-tumor response, whereas effector breaks the immunosuppression. We report efficacy of therapeutic melanoma vaccine (AGI-101H) used alone in advanced disease as a...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacek, Mackiewicz, Aldona, Karczewska-Dzionk, Maria, Laciak, Malgorzata, Kapcinska, Maciej, Wiznerowicz, Tomasz, Burzykowski, Zakowska, Monika, Stefan, Rose-John, Andrzej, Mackiewicz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616404/
https://www.ncbi.nlm.nih.gov/pubmed/26020391
http://dx.doi.org/10.1097/MD.0000000000000853

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616404/
https://www.ncbi.nlm.nih.gov/pubmed/26020391
http://dx.doi.org/10.1097/MD.0000000000000853

Ejemplares similares